MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Imunon Inc

Suletud

0.78 5.41

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.73

Max

0.8

Põhinäitajad

By Trading Economics

Töötajad

25

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+1650% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

13. aug 2025

Turustatistika

By TradingEconomics

Turukapital

4M

15M

Eelmine avamishind

-4.63

Eelmine sulgemishind

0.78

Imunon Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. juuli 2025, 23:45 UTC

Omandamised, ülevõtmised, äriostud

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3. juuli 2025, 23:42 UTC

Market Talk

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3. juuli 2025, 23:41 UTC

Market Talk

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3. juuli 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. juuli 2025, 23:15 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3. juuli 2025, 22:59 UTC

Market Talk

Uranium Market About to Enter Lull -- Market Talk

3. juuli 2025, 22:58 UTC

Market Talk

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3. juuli 2025, 22:47 UTC

Market Talk

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3. juuli 2025, 22:21 UTC

Tulu

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3. juuli 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

3. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. juuli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

3. juuli 2025, 20:41 UTC

Market Talk

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3. juuli 2025, 20:41 UTC

Market Talk

Global Equities Roundup: Market Talk

3. juuli 2025, 19:28 UTC

Market Talk

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3. juuli 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3. juuli 2025, 18:34 UTC

Market Talk

Gold Has Winning Week, But Down Day -- Market Talk

3. juuli 2025, 18:18 UTC

Market Talk

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3. juuli 2025, 18:06 UTC

Market Talk

Global Equities Roundup: Market Talk

3. juuli 2025, 18:06 UTC

Market Talk

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3. juuli 2025, 17:27 UTC

Market Talk

U.S. Oil Rig Count Continues to Slide -- Market Talk

3. juuli 2025, 16:55 UTC

Tulu

Travel Stocks Could Offer Investors a Glorious -2-

3. juuli 2025, 16:55 UTC

Tulu

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3. juuli 2025, 16:20 UTC

Market Talk

Correction to Health Care Roundup: Market Talk

3. juuli 2025, 16:15 UTC

Market Talk

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3. juuli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3. juuli 2025, 16:05 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. juuli 2025, 16:05 UTC

Market Talk

Gold Futures Fall Following Jobs Report -- Market Talk

3. juuli 2025, 15:47 UTC

Tulu

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3. juuli 2025, 15:36 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Imunon Inc Prognoos

Hinnasiht

By TipRanks

1650% tõus

12 kuu keskmine prognoos

Keskmine 14 USD  1650%

Kõrge 14 USD

Madal 14 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Imunon Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Finantsandmed

$

Ettevõttest Imunon Inc

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.